Vendor / Supplier Audits
In today’s globally interconnected pharmaceutical and biotech supply chains, your finished product quality is only as reliable as your weakest external partner—making rigorous Vendor / Supplier Audits an indispensable frontline defense against raw material adulteration, supply disruptions, and regulatory enforcement actions. Our service delivers an impartial, deep-dive evaluation of your entire external network—including API manufacturers, excipient suppliers, contract packaging organizations (CPOs), contract testing laboratories, and logistics providers—against the full spectrum of applicable FDA, EMA, ICH, and local regulatory requirements. We go far beyond cursory document reviews, deploying seasoned GMP/GLP auditors to physically or remotely dissect your suppliers’ quality management systems, manufacturing process controls, data governance frameworks, facility hygiene and maintenance practices, change control mechanisms, and supply chain traceability from incoming materials to outbound distribution. Every audit is meticulously risk-based and fully customizable to your product’s critical quality attributes (CQAs), ensuring we prioritize high-risk areas such as potential cross-contamination, data integrity vulnerabilities, and hidden subcontractor usage that often escape routine oversight.
Crucially, we do not simply hand you a report and walk away; we translate every audit observation into a prioritized, actionable supplier improvement roadmap, integrate findings into your CAPA ecosystem, and help you establish robust ongoing vendor qualification and performance monitoring metrics. Whether you are on-boarding a new strategic partner, managing a global panel of hundreds of suppliers, or responding to regulatory scrutiny over an outsourced operation, our audit expertise transforms external vendor management from a reactive compliance burden into a proactive, competitive differentiator that safeguards your brand, secures your supply chain, and fortifies your inspection readiness across every product lifecycle stage.
Contact us now if you are looking for:
- Supplier/Vendor Audits
- GMP Audits
- Quality System Audits
- Data Integrity Audits
- Gap Assessments
- Gap Analysis & CAPA Implementation
- QMS Development & Implementation
- Documentation & SOP Development
- Quality System Remediation
- Due diligence for purchase / acquisitions
FAQs
Vendor and supplier audits help pharmaceutical companies assess the quality systems, manufacturing practices, compliance status, and operational controls of external partners. Effective supplier oversight reduces quality risks, strengthens supply chain reliability, and supports compliance with GMP and regulatory expectations.
Organizations commonly audit API manufacturers, excipient suppliers, packaging material vendors, contract manufacturing organizations (CMOs), contract testing laboratories, logistics providers, and other suppliers whose products or services may directly impact product quality, patient safety, or regulatory compliance.
A supplier audit may assess quality management systems, manufacturing controls, documentation practices, data integrity controls, change management procedures, deviation handling, facility conditions, training programs, traceability systems, and overall compliance with applicable regulatory and quality requirements.
A risk-based approach focuses audit resources on suppliers, materials, and services that have the greatest potential impact on product quality and business continuity. This helps organizations prioritize critical suppliers and manage supply chain risks more effectively.
Supplier audits are commonly performed during vendor qualification, onboarding of new suppliers, periodic supplier requalification, significant quality events, major process changes, supply chain disruptions, regulatory concerns, or before entering strategic sourcing agreements.
Common observations may include documentation deficiencies, inadequate change control processes, data integrity weaknesses, training gaps, quality system shortcomings, poor deviation management practices, facility maintenance issues, traceability concerns, or supplier oversight deficiencies.
Regulatory agencies expect pharmaceutical manufacturers to maintain appropriate oversight of suppliers that impact product quality. Supplier audits provide documented evidence of vendor qualification, ongoing performance monitoring, risk management, and supply chain governance activities.
Following the audit, observations are typically categorized based on risk and impact. Corrective and preventive actions (CAPA), supplier improvement plans, follow-up assessments, and ongoing performance monitoring activities may be implemented to address identified gaps.
Supplier audits help identify potential quality, compliance, operational, and continuity risks before they affect manufacturing operations. A structured supplier qualification program supports stronger supplier relationships, better risk management, and improved supply chain resilience.
Yes. Remote audits can be used to review documentation, quality systems, procedures, records, and selected operational controls. Depending on risk level, product criticality, and regulatory expectations, remote assessments may complement or supplement on-site audits as part of a broader supplier oversight strategy.